http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275036-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24fa0965b1062756c0559b985e1b83b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 |
| filingDate | 2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f10ee823a61d2f7f325f5e1ed490d4d |
| publicationDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103275036-A |
| titleOfInvention | Piperidine derivatives and preparation method thereof |
| abstract | The invention discloses novel piperidine derivatives which are represented by the following general formula (I). The derivatives are a muscarine acetylcholinergic receptor selective antagonist, wherein R1 and R2 respectively independently represent a hydrogen atom or straight-chain or branched-chain alkyl group containing 1-3 carbon atoms, and R3 represents a hydrogen atom or halogen. Besides, the invention also discloses a preparation method of the derivatives and application of the derivatives as a muscarine acetylcholinergic receptor antagonist. |
| priorityDate | 2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.